Clinical Trial Update: A Trial to Evaluate the Lot-to-lot Consistency of Live Attenuated Varicella Vaccine in Healthy People 1-12 Years of Age [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating lot-to-lot consistency of a live attenuated varicella vaccine in healthy children aged 1–12 years.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Varicella

Drugs mentioned

• Live Attenuated Varicella Vaccine (varicella vaccine, live attenuated)

Snippet

Sponsor: China National Biotec Group Company Limited | Conditions: Varicella | Phase 3 | Status: UNKNOWN